KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Dividends Paid - Common (2016 - 2025)

Pfizer (PFE) has disclosed Dividends Paid - Common for 17 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Dividends Paid - Common rose 2.73% to $2.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $9.8 billion, a 2.72% increase, with the full-year FY2025 number at $9.8 billion, up 2.72% from a year prior.
  • Dividends Paid - Common was $2.4 billion for Q4 2025 at Pfizer, roughly flat from $2.4 billion in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $6.7 billion in Q4 2022 to a low of $2.2 billion in Q2 2021.
  • A 5-year average of $2.8 billion and a median of $2.4 billion in 2024 define the central range for Dividends Paid - Common.
  • Peak YoY movement for Dividends Paid - Common: grew 3.55% in 2022, then crashed 65.66% in 2023.
  • Pfizer's Dividends Paid - Common stood at $6.5 billion in 2021, then grew by 3.03% to $6.7 billion in 2022, then crashed by 65.64% to $2.3 billion in 2023, then grew by 2.81% to $2.4 billion in 2024, then increased by 2.73% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Dividends Paid - Common are $2.4 billion (Q4 2025), $2.4 billion (Q3 2025), and $2.4 billion (Q2 2025).